Me Research Institute, a nonprofit medical research organization, announced the publication of a study that identifies ...
At-home health testing platform Ash is expanding its partnership with weight-loss company Noom to bring Noom's Proactive Health Microdose GLP-1Rx Program to market. Noom's program, launched in August, ...
BENTONVILLE, Ark. (KNWA/KFTA) — GLP-1 blood testing is now being offered at select Sam’s Club locations in Texas through a partnership with Babson Diagnostics. The companies say the GLP-1 Test Panel ...
A new study identified genetic variants that researchers say can affect pounds lost while taking a GLP-1 drug.
Phenomix's MyPhenome test continues to demonstrate predictive accuracy in identifying which patients are most likely to respond to GLP-1 therapies such as semaglutide. Studies presented at Obesity ...
In new research to be presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey (12–15 May), a global panel of 21 obesity and cancer experts suggest that to test the potential ...
Common GLP-1s include semaglutides like Ozempic and Wegovy, and tirzepatides like Zepbound and Mounjaro. These drugs work by mimicking a natural hormone to regulate appetite, blood sugar, and feelings ...
McDonald's is jumping on the protein bandwagon, with CEO Chris Kempczinski expressing interest in introducing more GLP-1-friendly food items to the popular chain's menu. Speaking at an earnings call ...
Accumulating scientific evidence and industry interest from Eli Lilly, Altimmune and startup Baseline Therapeutics is driving further research on the therapeutic potential of GLP-1 receptor agonists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results